| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Forte Biosciences, Inc. | Director | Stock Option (right to buy) | 31,000 | 20 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| FBRX | Forte Biosciences, Inc. | 20 Mar 2025 | 1 | $0 | 4 | Director | 21 Mar 2025, 16:45 |
| FBRX | Forte Biosciences, Inc. | 20 Aug 2024 | 1 | $0 | 4 | Director | 22 Aug 2024, 16:10 |
| FBRX | Forte Biosciences, Inc. | 19 Sep 2023 | 1 | $0 | 4 | Director | 20 Sep 2023, 17:53 |
| FBRX | Forte Biosciences, Inc. | 31 Jul 2023 | 1 | +$99,999 | 4 | Director | 02 Aug 2023, 18:03 |
| FBRX | Forte Biosciences, Inc. | 01 Jun 2022 | 1 | $0 | 4 | Director | 02 Jun 2022, 17:12 |
| FBRX | Forte Biosciences, Inc. | 23 Feb 2022 | 1 | $0 | 4 | Director | 24 Feb 2022, 16:04 |
| FBRX | Forte Biosciences, Inc. | 28 May 2021 | 1 | $0 | 4 | Director | 01 Jun 2021, 19:25 |